EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing

Zuzana Holesova iD, Jaroslav Budis, Marcel Kucharik iD, Juraj Gazdarica, Daria Carska, Gabriel Minarik, Michaela Hyblova, Tomas Szemes

PLOS One · 2025

DOI: 10.1371/journal.pone.0327714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Zuzana Holesova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Geneton Ltd, Bratislava, Slovakia. Hauptthemen laut MEDLINE: Telomere, Fetus, Prenatal Diagnosis, Noninvasive Prenatal Testing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, Recovery plan for Europe.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-invasive prenatal testing (NIPT) has revolutionized prenatal diagnostics by providing a safer alternative to invasive techniques such as amniocentesis and chorionic villus sampling. NIPT detects chromosomal abnormalities through the analysis of cell-free fetal DNA (cffDNA) in maternal plasma. One of the critical factors influencing accuracy of NIPT is the fetal fraction (FF) – the proportion of fetal cell-free DNA relative to total cell-free DNA in maternal plasma. This study investigates the potential of using telomere length measurements as a novel biomarker for fetal fraction prediction in NIPT. Telomere-derived fragments, which differ between maternal and fetal DNA, may serve as a measure of FF due to the distinct telomere length. Specifically, deviations from the expected shorter telomere lengths of maternal DNA toward longer lengths could be more pronounced at higher FF levels. Various models incorporating telomere content and features selected by Ordinary Least Squares (OLS) were evaluated to enhance fetal fraction prediction. Our results showed that telomere content also works as an independent predictor (with Pearson correlation 0.23), yielding a small improvement in prediction precision when combined with traditional models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomereFetusPrenatal DiagnosisNoninvasive Prenatal TestingTelomere HomeostasisHumansFemalePregnancyBiomarkersCell-Free Nucleic AcidsAdult

Substanzen

BiomarkersCell-Free Nucleic Acids

Autor:innen und Institutionen

  • Geneton Ltd, Bratislava, Slovakia.
  • Comenius University Science Park, Bratislava, Slovakia.
  • Slovak Centre of Scientific and Technical Information, Bratislava, Slovakia.
  • Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
  • TRISOMYtest Ltd, Nitra, Slovakia.
  • Medirex Group Academy, Nitra, Slovakia.

ORCID-Profile: Zuzana Holesova, Marcel Kucharik

Förderung

  • NextGenerationEU, Recovery plan for Europe

Zitieren

APA

Holesova, Z., Budis, J., Kucharik, M., Gazdarica, J., Carska, D., Minarik, G., Hyblova, M., & Szemes, T. (2025). Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing. PLOS One. https://doi.org/10.1371/journal.pone.0327714

Vancouver

Holesova Z, Budis J, Kucharik M, Gazdarica J, Carska D, Minarik G, et al. Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing. PLOS One. 2025. doi:10.1371/journal.pone.0327714

BibTeX
@article{Holesova2025,
  author = {Holesova, Zuzana and Budis, Jaroslav and Kucharik, Marcel and Gazdarica, Juraj and Carska, Daria and Minarik, Gabriel and Hyblova, Michaela and Szemes, Tomas},
  title = {Telomere length as a biomarker for fetal fraction prediction in non-invasive prenatal testing},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0327714}
}
Kostenlos starten →